Pathogenic SMAD6 variants in patients with idiopathic and complex congenital heart disease associated pulmonary arterial hypertension

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Sofia Karl - , Heidelberg University  (Author)
  • Ekkehard Grünig - , Heidelberg University  (Author)
  • Memoona Shaukat - , Heidelberg University  (Author)
  • Matthias Held - , Clinic Würzburg Mitte gGmbH (Author)
  • Christian Apitz - , Ulm University (Author)
  • Fabian von Scheidt - , Technical University of Munich (Author)
  • Ralf Geiger - , Innsbruck Medical University (Author)
  • Michael Halank - , Department of Internal Medicine I, University Hospital Carl Gustav Carus Dresden (Author)
  • Karen M. Olsson - , Hannover Medical School (MHH) (Author)
  • Marius M. Hoeper - , Hannover Medical School (MHH) (Author)
  • Jan C. Kamp - , Hannover Medical School (MHH) (Author)
  • Gabor Kovacs - , Medical University of Graz (Author)
  • Horst Olschewski - , Medical University of Graz (Author)
  • Hans Jürgen Seyfarth - , Leipzig University (Author)
  • Katrin Milger - , Ludwig Maximilian University of Munich (Author)
  • Ralf Ewert - , University of Greifswald (Author)
  • Hans Klose - , University of Hamburg (Author)
  • Benjamin Egenlauf - , Heidelberg University  (Author)
  • Panagiota Xanthouli - , Heidelberg University  (Author)
  • Katrin Hinderhofer - , Heidelberg University  (Author)
  • Christina A. Eichstaedt - , Heidelberg University  (Author)

Abstract

In patients with complex congenital heart disease (CHD) pathogenic SMAD6 variants have been described previously. The aim of this study was to analyze if pathogenic SMAD6 variants also occur in patients with CHD associated with pulmonary arterial hypertension (CHD-APAH) or idiopathic PAH. A PAH gene panel with up to 64 genes including SMAD6 was used to sequence 311 patients with idiopathic PAH (IPAH) and 32 with CHD-APAH. In 4 of 32 (12.5%) CHD-APAH and in 2 out of 311 (0.64%) IPAH patients we identified likely pathogenic or rare SMAD6 missense variants. All CHD-APAH patients with a rare SMAD6 variant had complex CHD. One patient had bi-allelic SMAD6 variants, combined pulmonary valve defect and supravalvular aortic stenosis, craniosynostosis and radioulnar synostosis. This is the first description of potentially disease-causing SMAD6 variants in patients with IPAH and complex CHD-APAH. Further studies are needed to assess pathogenesis and prevalence of pathogenic SMAD6 variants in PAH.

Details

Original languageEnglish
Article number28
Journalnpj Genomic Medicine
Volume10
Issue number1
Publication statusPublished - 25 Mar 2025
Peer-reviewedYes

External IDs

PubMed 40133303

Keywords